Pantelidou, C., Sonzogni, O., De Oliveria Taveira, M., Mehta, A. K., Kothari, A., Wang, D., . . . Shapiro, G. I. (2019). PARP inhibitor efficacy depends on CD8+ T cell recruitment via intratumoral STING pathway activation in BRCA-deficient models of triple-negative breast cancer. Cancer Discov.
Citação norma ChicagoPantelidou, Constantia, et al. "PARP Inhibitor Efficacy Depends On CD8+ T Cell Recruitment Via Intratumoral STING Pathway Activation in BRCA-deficient Models of Triple-negative Breast Cancer." Cancer Discov 2019.
MLA CitationPantelidou, Constantia, et al. "PARP Inhibitor Efficacy Depends On CD8+ T Cell Recruitment Via Intratumoral STING Pathway Activation in BRCA-deficient Models of Triple-negative Breast Cancer." Cancer Discov 2019.